Back to search

Article

Single-cell level characterization of B cell depletion and repopulation following rituximab in systemic lupus erythematosus

2025-05-28

Abstract excerpt

<h4>Objective</h4> Rituximab, a CD20 + B cell depletion therapy, is frequently used in the treatment of systemic lupus erythematosus (SLE). However, variability in patient response highlights the need for a deeper understanding of the underlying immune cell dynamics of B cell depletion and repopulation. <h4>Methods</h4> In this study, we conducted longitudinal single-cell profiling of nine SLE patients treated wit...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c4f33878-eb94-5ffa-a6dd-5c3601c94964
DOI
10.1101/2025.05.27.25328230
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Single-cell level characterization of B cell depletion and repopulation following rituximab in systemic lupus erythematosusDOI 10.1101/2025.05.27.25328230
Select a neighboring publication to make it the new centre.